254 related articles for article (PubMed ID: 28399020)
1. Therapeutic microRNAs in polycystic kidney disease.
Yheskel M; Patel V
Curr Opin Nephrol Hypertens; 2017 Jul; 26(4):282-289. PubMed ID: 28399020
[TBL] [Abstract][Full Text] [Related]
2. microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism.
Hajarnis S; Lakhia R; Yheskel M; Williams D; Sorourian M; Liu X; Aboudehen K; Zhang S; Kersjes K; Galasso R; Li J; Kaimal V; Lockton S; Davis S; Flaten A; Johnson JA; Holland WL; Kusminski CM; Scherer PE; Harris PC; Trudel M; Wallace DP; Igarashi P; Lee EC; Androsavich JR; Patel V
Nat Commun; 2017 Feb; 8():14395. PubMed ID: 28205547
[TBL] [Abstract][Full Text] [Related]
3. Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growth.
Yheskel M; Lakhia R; Cobo-Stark P; Flaten A; Patel V
Sci Rep; 2019 Feb; 9(1):1920. PubMed ID: 30760828
[TBL] [Abstract][Full Text] [Related]
4. Modulation of polycystic kidney disease by non-coding RNAs.
Ramalingam H; Yheskel M; Patel V
Cell Signal; 2020 Jul; 71():109548. PubMed ID: 31982550
[TBL] [Abstract][Full Text] [Related]
5. Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease.
Kim DY; Woo YM; Lee S; Oh S; Shin Y; Shin JO; Park EY; Ko JY; Lee EJ; Bok J; Yoo KH; Park JH
FASEB J; 2019 Feb; 33(2):2870-2884. PubMed ID: 30332302
[TBL] [Abstract][Full Text] [Related]
6. miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease.
Patel V; Williams D; Hajarnis S; Hunter R; Pontoglio M; Somlo S; Igarashi P
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10765-70. PubMed ID: 23759744
[TBL] [Abstract][Full Text] [Related]
7. Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease.
Lee EC; Valencia T; Allerson C; Schairer A; Flaten A; Yheskel M; Kersjes K; Li J; Gatto S; Takhar M; Lockton S; Pavlicek A; Kim M; Chu T; Soriano R; Davis S; Androsavich JR; Sarwary S; Owen T; Kaplan J; Liu K; Jang G; Neben S; Bentley P; Wright T; Patel V
Nat Commun; 2019 Sep; 10(1):4148. PubMed ID: 31515477
[TBL] [Abstract][Full Text] [Related]
8. Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression.
Lakhia R; Yheskel M; Flaten A; Ramalingam H; Aboudehen K; Ferrè S; Biggers L; Mishra A; Chaney C; Wallace DP; Carroll T; Igarashi P; Patel V
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32182218
[TBL] [Abstract][Full Text] [Related]
9. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.
Streets AJ; Magayr TA; Huang L; Vergoz L; Rossetti S; Simms RJ; Harris PC; Peters DJ; Ong AC
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F577-F588. PubMed ID: 28077374
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of MiR-199a-5p reduced cell proliferation in autosomal dominant polycystic kidney disease through targeting CDKN1C.
Sun L; Zhu J; Wu M; Sun H; Zhou C; Fu L; Xu C; Mei C
Med Sci Monit; 2015 Jan; 21():195-200. PubMed ID: 25588980
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21 Aggravates Cyst Growth in a Model of Polycystic Kidney Disease.
Lakhia R; Hajarnis S; Williams D; Aboudehen K; Yheskel M; Xing C; Hatley ME; Torres VE; Wallace DP; Patel V
J Am Soc Nephrol; 2016 Aug; 27(8):2319-30. PubMed ID: 26677864
[TBL] [Abstract][Full Text] [Related]
12. Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum.
van Gulick JJ; Gevers TJ; van Keimpema L; Drenth JP
Neth J Med; 2011 Sep; 69(9):367-71. PubMed ID: 21978978
[TBL] [Abstract][Full Text] [Related]
13. Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation.
Lee EJ; Park EY; Mun H; Chang E; Ko JY; Kim DY; Park JH
FASEB J; 2015 Aug; 29(8):3506-14. PubMed ID: 25934702
[TBL] [Abstract][Full Text] [Related]
14. Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline.
Ben-Dov IZ; Tan YC; Morozov P; Wilson PD; Rennert H; Blumenfeld JD; Tuschl T
PLoS One; 2014; 9(1):e86856. PubMed ID: 24489795
[TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant polycystic kidney disease: pathophysiology and treatment.
McCarthy S; McMullen M
ANNA J; 1997 Feb; 24(1):45-51; quiz 52-3. PubMed ID: 9146123
[TBL] [Abstract][Full Text] [Related]
16. Profiling of miRNAs and target genes related to cystogenesis in ADPKD mouse models.
Woo YM; Kim DY; Koo NJ; Kim YM; Lee S; Ko JY; Shin Y; Kim BH; Mun H; Choi S; Lee EJ; Shin JO; Park EY; Bok J; Park JH
Sci Rep; 2017 Oct; 7(1):14151. PubMed ID: 29074972
[TBL] [Abstract][Full Text] [Related]
17. Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney disease.
Ali H; Malik MZ; Abu-Farha M; Abubaker J; Cherian P; Nizam R; Jacob S; Bahbahani Y; Naim M; Ahmad S; Al-Sayegh M; Thanaraj TA; Ong ACM; Harris PC; Al-Mulla F
J Gene Med; 2024 Feb; 26(2):e3674. PubMed ID: 38404150
[TBL] [Abstract][Full Text] [Related]
18. Tiny Non-coding RNAs in Body Fluids, Possible Biomarkers for Autosomal Dominant Polycystic Kidney Disease.
Ghasemi Y; Tayebi-Khosroshahi H; Abedi B; Rahmati-Yamchi M; Alizadeh E
Iran J Kidney Dis; 2019 May; 13(3):151-164. PubMed ID: 31209188
[TBL] [Abstract][Full Text] [Related]
19. Urinary MicroRNAs, Possible Biomarkers for Early Detection of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Ghasemi Y; Mardomi A; Alizadeh E; Khosroshahi HT
Iran J Kidney Dis; 2023 Mar; 1(2):73-78. PubMed ID: 37060340
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]